• Project status: Active
Child with cancer standing outside

We want to know your questions about bone marrow transplants (BMT).

We want to know what questions you have about bone marrow transplants (BMT), with a focus on the time between BMT treatment up until day 180 (six months) following a BMT.

Through this, we aim to identify bone marrow transplant research priorities in Australia, New Zealand, United Kingdom and Europe for children and adolescents requiring BMT.

Fill in the survey

We want to know what questions you have about bone marrow transplants (BMT), with a focus on the time between BMT treatment up until day 180 (six months) following a BMT.

Through this, we aim to identify bone marrow transplant research priorities in...

We want to know what questions you have about bone marrow transplants (BMT), with a focus on the time between BMT treatment up until day 180 (six months) following a BMT.

Through this, we aim to identify bone marrow transplant research priorities in Australia, New Zealand, United Kingdom and Europe for children and adolescents requiring BMT.

Fill in the survey

Overview

This study is designed to improve the lives of children who are undergoing a BMT.

Our aim is to identify questions that are important to patients, families, healthcare workers and the community which are not currently addressed by research, also known as unanswered questions. The results of this study will help ensure that future research focuses on the needs of children requiring a BMT. 

This survey will be distributed throughout Australia, New Zealand, United Kingdom and Europe.

This study is being funded by the Victorian Paediatric Cancer Consortium (VPCC). The VPCC is a collaboration of academic, research and clinical organisations which advance research for patients with cancer. 

How the study is run

This study follows the scientific methods of the James Lind Alliance (JLA). 

Research on the effects of treatments often overlooks the shared interests of patients, carers and clinicians. As a result, the questions that they consider important are not addressed equally, and many areas of potentially important research are therefore neglected.

The JLA method aims to address this imbalance.

In this method, a range of representatives including patients who had a BMT as a child, their parents or carers, clinicians and allied health professionals make up a steering group guided by a neutral JLA adviser. Each representative has equal input on the direction of the study.

A JLA study brings patients, caregivers, researchers and clinicians together in priority setting partnerships (PSPs). The aim of a PSP is to help ensure that those who fund health research are aware of what really matters to patients, caregivers and clinicians.

More information

child in hospital

Tomorrow's cures need your donations today

Donate now